Skip to main content
Fig. 3 | World Journal of Surgical Oncology

Fig. 3

From: A new marker constructed from immune-related lncRNA pairs can be used to predict clinical treatment effects and prognosis: in-depth exploration of underlying mechanisms in HNSCC

Fig. 3

We used risk plots and survival point map, survival curves, and 1-, 2-, and 3-year multi-factor ROC curve to assess the performance of the prognostic model, which was respectively established by the data in the TCGA training set, test set, and the whole set. A–C Risk plots and survival point map. D–F Survival curves. G 1-year multi-factor ROC curves. H 2-year multi-factor ROC curves. I 3-year multi-factor ROC curves

Back to article page